Vivos (RDGL) Assets Growth (3y) (2013 - 2025)
Vivos (RDGL) Assets Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.33% |
| Sep 30, 2025 | 3.90% |
| Jun 30, 2025 | 35.81% |
| Mar 31, 2025 | 36.16% |
| Dec 31, 2024 | 10.97% |
| Sep 30, 2024 | -15.24% |
| Jun 30, 2024 | -7.46% |
| Mar 31, 2024 | -18.13% |
| Dec 31, 2023 | 19.75% |
| Sep 30, 2023 | 200.20% |
| Jun 30, 2023 | 81.45% |
| Dec 31, 2022 | 241.20% |
| Sep 30, 2022 | 118.16% |
| Jun 30, 2022 | 184.17% |
| Mar 31, 2022 | 183.63% |
| Dec 31, 2021 | 362.81% |
| Sep 30, 2021 | 458.51% |
| Jun 30, 2021 | 549.18% |
| Mar 31, 2021 | 1,443.53% |
| Dec 31, 2020 | 290.89% |